Home Page

Pre-cancerous signatures found in healthy tissue point the way towards new treatment options

Appointments and changes to the Genome Research Limited Board
At the GRL Board meeting on 2 December 2019, David Willetts announced his intention to step down as Chair because of his extensive commitments across the academic and science sectors
Wellcome's Director, Jeremy Farrar, will take over the Chair of GRL Board from 1 January 2020. The change in leadership comes as the Wellcome Genome Campus prepares to embark on an ambitious transformation project ...more
Our 2018/2019 Highlights document is out now
Explore our key discoveries and future research interests in our online interactive PDF
Over the past year we have provided new insights into human, parasite and microbe evolution, cellular development, and the mutational processes that lead to cancer. We also launched our latest research programme, the Tree of Life ...more